Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER IMMUNOTHERAPY

PAK4 as a cancer immune-evasion target

Nature Cancer volume 1, pages 18–19 (2020)Cite this article

Subjects

Immunotherapy resistance is associated with poor T cell infiltration into tumors. Tumor-cell-intrinsic oncogenic events that contribute to this defect include Wnt–β-catenin activation. PAK4 is now identified as an upstream modulator of this pathway, thus suggesting the potential of enhancing the efficacy of immunotherapy by targeting this druggable kinase.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The role of PAK4 in tumor-intrinsic Wnt–β-catenin signaling and the anti-tumor immune response.

References

  1. Tumeh, P. C. et al. Nature 515, 568–571 (2014).

    Article  CAS  Google Scholar 

  2. Ayers, M. et al. J. Clin. Invest. 127, 2930–2940 (2017).

    Article  Google Scholar 

  3. Ribas, A. Cancer Discov. 5, 915–919 (2015).

    Article  CAS  Google Scholar 

  4. Gajewski, T. F. et al. Curr. Opin. Immunol. 25, 268–276 (2013).

    Article  CAS  Google Scholar 

  5. Spranger, S. & Gajewski, T. F. Nat. Rev. Cancer 18, 139–147 (2018).

    Article  CAS  Google Scholar 

  6. Spranger, S., Bao, R. & Gajewski, T. F. Nature 523, 231–235 (2015).

    Article  CAS  Google Scholar 

  7. Abril-Rodríguez, G. et al. Nat. Cancer https://doi.org/10.1038/s43018-019-0003-0 (2019).

  8. Peng, W. et al. Cancer Discov. 6, 202–216 (2016).

    Article  CAS  Google Scholar 

  9. Sweis, R. F. et al. Cancer Immunol. Res. 4, 563–568 (2016).

    Article  CAS  Google Scholar 

  10. Skoulidis, F. et al. Cancer Discov. 8, 822–835 (2018).

    Article  CAS  Google Scholar 

  11. Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G. & Gajewski, T. F. Science 359, 1366–1370 (2018).

    Article  CAS  Google Scholar 

  12. Chat, V. et al. Cancer Immunol. Immunother. 68, 897–905 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Chicago, Chicago, IL, USA

    Thomas F. Gajewski & Jessica Fessler

Authors
  1. Thomas F. Gajewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica Fessler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas F. Gajewski.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gajewski, T.F., Fessler, J. PAK4 as a cancer immune-evasion target. Nat Cancer 1, 18–19 (2020). https://doi.org/10.1038/s43018-019-0012-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-019-0012-z

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer